Acenaphtho[1,2‐d][1,2,3]triazole and Its Kuratowski Complex: A π‐Extended Tecton for Supramolecular and Coordinative Self‐Assembly.

Autor: Knippen, Katharina¹ (AUTHOR), Matuszczyk, Daniel² (AUTHOR), Kraft, Maryana¹ (AUTHOR), Bredenkötter, Björn¹ (AUTHOR), Eickerling, Georg³ (AUTHOR), Lis, Tadeusz² (AUTHOR), Volkmer, Dirk¹ (AUTHOR) dirk.volkmer@physik.uni-augsburg.de, Stępień, Marcin² (AUTHOR) marcin.stepien@chem.uni.wroc.pl

Publikováno v: Chemistry - A European Journal. 1/19/2022, Vol. 28 Issue 4, p1-6. 6p.

CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's disease.

Autor: Picó S; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain., Parras A; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain., Santos-Galindo M; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain., Pose-Utrilla J; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.; Instituto de Investigaciones Biomédicas 'Alberto Sols,' Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid 28029, Spain., Castro M; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Centro de Diagnóstico de Enfermedades Moleculares (CEDEM), Madrid 28049, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid,28029, Spain., Fraga E; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain., Hernández IH; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.; Facultad de Ciencias, Departamento de Biología (Unidad Docente Fisiología Animal), Universidad Autónoma de Madrid, Madrid 28049, Spain., Elorza A; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain., Anta H; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Unidad Asociada I+D+i IMIM-IIBB (CSIC), Barcelona 08003, Spain.; Institute for Research in Biomedicine (IRB), Barcelona Institute of Science and Technology, Barcelona 08028, Spain., Wang N; Center for Neurobehavioral Genetics, Jane and Terry Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA., Martí-Sánchez L; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid,28029, Spain.; Department of Clinical Biochemistry, Institut de Recerca Sant Joan de Déu, Barcelona 08950, Spain., Belloc E; Institute for Research in Biomedicine (IRB), Barcelona Institute of Science and Technology, Barcelona 08028, Spain., Garcia-Esparcia P; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.; Institute of Neuropathology, IDIBELL-University Hospital Bellvitge, University of Barcelona, Hospitalet de Llobregat, Barcelona 08908, Spain., Garrido JJ; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.; Department of Molecular, Cellular, and Developmental Neurobiology, Instituto Cajal (CSIC), Madrid 28002, Spain., Ferrer I; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.; Institute of Neuropathology, IDIBELL-University Hospital Bellvitge, University of Barcelona, Hospitalet de Llobregat, Barcelona 08908, Spain., Macías-García D; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla 41013, Spain., Mir P; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla 41013, Spain., Artuch R; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid,28029, Spain.; Department of Clinical Biochemistry, Institut de Recerca Sant Joan de Déu, Barcelona 08950, Spain., Pérez B; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Centro de Diagnóstico de Enfermedades Moleculares (CEDEM), Madrid 28049, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid,28029, Spain., Hernández F; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain., Navarro P; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Unidad Asociada I+D+i IMIM-IIBB (CSIC), Barcelona 08003, Spain.; Institute of Biomedical Research of Barcelona (IIBB-CSIC), Barcelona 08036, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain., López-Sendón JL; Department of Neurology, Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28034, Spain., Iglesias T; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.; Instituto de Investigaciones Biomédicas 'Alberto Sols,' Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid 28029, Spain., Yang XW; Center for Neurobehavioral Genetics, Jane and Terry Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA., Méndez R; Institute for Research in Biomedicine (IRB), Barcelona Institute of Science and Technology, Barcelona 08028, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain., Lucas JJ; Center for Molecular Biology 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, 28049, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, 28031, Spain.

Publikováno v: Science translational medicine [Sci Transl Med] 2021 Sep 29; Vol. 13 (613), pp. eabe7104. Date of Electronic Publication: 2021 Sep 29.

CPEB2-activated axonal translation of VGLUT2 mRNA promotes glutamatergic transmission and presynaptic plasticity.

Autor: Lu, Wen-Hsin¹ (AUTHOR), Chang, Tzu-Tung¹ (AUTHOR), Chang, Yao-Ming¹ (AUTHOR), Liu, Yi-Hsiang¹ (AUTHOR), Lin, Chia-Hsuan^1,2 (AUTHOR), Suen, Ching-Shu¹ (AUTHOR), Hwang, Ming-Jing¹ (AUTHOR), Huang, Yi-Shuian^1,2,3 (AUTHOR) yishuian@ibms.sinica.edu.tw

Publikováno v: Journal of Biomedical Science. 7/11/2024, Vol. 31 Issue 1, p1-19. 19p.

Unveiling a Microexon Switch: Novel Regulation of the Activities of Sugar Assimilation and Plant-Cell-Wall-Degrading Xylanases and Cellulases by Xlr2 in Trichoderma virens.

Autor: Castañeda-Casasola, Cynthia Coccet^1,2,3 (AUTHOR) anducho@upp.edu.mx, Nieto-Jacobo, María Fernanda⁴ (AUTHOR) fernanda.jacobo@plantandfood.co.nz, Soares, Amanda¹ (AUTHOR) amaanda_soares@hotmail.com, Padilla-Padilla, Emir Alejandro^1,5,6 (AUTHOR) chris.brown@otago.ac.nz, Anducho-Reyes, Miguel Angel² (AUTHOR), Brown, Chris⁵ (AUTHOR), Soth, Sereyboth¹ (AUTHOR) sereyboth.soth@lincolnuni.ac.nz, Esquivel-Naranjo, Edgardo Ulises^1,7 (AUTHOR) edgardo.esquivel@lincoln.ac.nz, Hampton, John¹ (AUTHOR) john.hampton@lincoln.ac.nz, Mendoza-Mendoza, Artemio¹ (AUTHOR) artemio.mendoza@lincoln.ac.nz

Publikováno v: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5172. 26p.

The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer.

Autor: Martínez-Bosch N; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Guerrero PE; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Moreno M; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., José A; Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain., Iglesias M; Pathology Service, Hospital del Mar, Barcelona, Spain., Munné-Collado J; Pathology Service, Hospital del Mar, Barcelona, Spain., Anta H; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain., Gibert J; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Orozco CA; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Vinaixa J; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Fillat C; Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain., Viñals F; Catalan Institute of Oncology-IDIBELL, Barcelona University, Barcelona, Spain., Navarro P; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

Publikováno v: Oncotarget [Oncotarget] 2016 Jul 26; Vol. 7 (30), pp. 48265-48279.